Back to top

Morgan Stanley Keeps Their Buy Rating on Insmed (INSM)

In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Insmed, with a price target of $212.00. Skor covers the Hea...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insmed, Inc. (INSM)